Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A new method to make finasteride for hair loss treatment was developed.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Analog 23 is a promising compound for prostate cancer treatment.

Clascoterone is safe for the heart, even at high doses.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

Biotin mega-dose therapy led to dramatic improvement in a newborn with a rare metabolic disorder.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

New methods can detect finasteride's major urinary metabolite in urine for up to 49 hours.

Oral contraceptives are generally recommended for healthy young girls, but specific types may vary based on individual health conditions and barrier methods are less popular among adolescents.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

Sodium valproate can rarely cause curly hair in children.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

A new compound that could treat various androgen-related conditions was created and analyzed.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.